论文部分内容阅读
目的:探讨肝病患者红细胞参数的改变对临床的意义。方法:回顾性分析2009年7月-2010年6月61例肝病患者和58例健康体检者红细胞参数的检测结果,并进行统计学比较。结果:同健康体检者比较,肝病患者红细胞参数中的红细胞数(RBC)、血红蛋白浓度(HGB)、血细胞比容(Hct)三项的检测结果明显降低,差异有统计学意义(P<0.05);红细胞平均容积(MCV)、红细胞体积分布宽度(RDW%)的检测结果则明显升高,差异有统计学意义(P<0.05);红细胞平均血红蛋白含量(MCH)、红细胞平均血红蛋白浓度(MCHC)两项的检测结果和健康体检者接近,差异无统计学意义(P>0.05)。结论:肝病患者红细胞参数的变化,特别是RBC、Hb、HCT、RDW与MCV可以反映肝病患者的肝损害程度和病情程度,且与肝病患者的预后关系密切,在指导临床治疗意义重大,应引起临床高度重视。
Objective: To investigate the clinical significance of the change of erythrocyte parameters in patients with liver disease. Methods: The data of erythrocyte parameters of 61 patients with liver disease and 58 healthy subjects from July 2009 to June 2010 were retrospectively analyzed and statistically compared. Results: Compared with healthy subjects, the results of RBC, HGB and Hct in liver disease patients were significantly lower (P <0.05) (P <0.05); the average of hemoglobin (MCH), the average hemoglobin concentration of erythrocytes (MCHC) The two test results and health examination close, the difference was not statistically significant (P> 0.05). Conclusion: The changes of erythrocyte parameters in patients with liver diseases, especially RBC, Hb, HCT, RDW and MCV, can reflect the extent of liver damage and severity of disease in patients with liver disease, and are closely related to the prognosis of patients with liver disease, which is of great significance in guiding the clinical treatment and should cause Clinical attention.